HJC0152 suppresses human non–small‐cell lung cancer by inhibiting STAT3 and modulating metabolism

OBJECTIVES: Signal transducer and activator of transcription 3 (STAT3) is constitutively activated and overexpressed in many cancers, including non–small‐cell lung cancer (NSCLC). We recently developed HJC0152 as an orally active STAT3 inhibitor. This study focused on investigating HJC0152's ef...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Prolif
Main Authors: Lu, Lu, Li, Hang, Wu, Xin, Rao, Jun, Zhou, Jia, Fan, Saijun, Shen, Qiang
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7106968/
https://ncbi.nlm.nih.gov/pubmed/32022328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12777
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares